English Deutsch Español Italiano CONTACT US
Woman reading paper.

Newsroom / Press Releases

Contact: media.relations@hra-pharma.com



December 16, 2011
Paris, France

HRA Pharma’s partner, Preglem, the wholly owned subsidiary of Gedeon Richter Plc., receives positive CHMP opinion for uterine fibroids treatment.

December 5, 2011
Paris, France & Budapest, Hungary

HRA Pharma grants Richter marketing rights for Esmya for China, Russia and other CIS republics

November 17, 2011
Paris, France

Riverside provides growth capital to France's HRA Pharma

October 10, 2011
Paris, France

HRA Pharma wins the 2011 Prix de l'Ambition

September 20, 2011
Paris, France and Singapore

ella® approved in Singapore

September 20, 2011
Seoul, South Korea and Paris, France

First Launch of ellaOne® in Asia

May 24, 2011
Tokyo, Japan and Paris, France

HRA Pharma welcomes the launch of NorLevo® as the first Emergency Contraceptive Pill to become available in Japan

May 20, 2011
Tokyo, Japan and Paris, France

ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ulipristal acetate to treat uterine fibroids in Japan

May 19th, 2011
Tokyo, Japan and Paris, France

ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ellaOne® in Japan

February 23, 2011
Paris, France

NorLevo® the First Emergency Contraceptive to Receive Marketing Approval in Japan.

February 16, 2010
Paris, France

HRA Pharma's NorLevo® Now the First Emergency Contraceptive Available Without a Prescription in Ireland.

December 20, 2010
Paris, France

HRA Pharma Enters into Agreement with Chemo to Commercialize Novel Emergency Contraceptive in Central and South America.

December 2, 2010
Paris, France
Seoul, South Korea

Shin Poong Pharma and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate in South Korea.

December 1, 2010
Paris, France

HRA Pharma’s Emergency Contraceptive ella® Now Available in the U.S.

September 20, 2010
Paris, France

ellaOne® now reimbursed in France.

September 17, 2010
Paris, France & Morristown, NJ, U.S.

HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada.

September 17, 2010
Paris, France

Erin Gainer, CEO of HRA Pharma, Recognized for Her Leadership Role in the Pharmaceutical Industry.

August 13, 2010
Paris, France

FDA grants approval of ella® for emergency contraception.

July 15, 2010
Paris, France

Ulipristal acetate (ellaOne®) significantly reduces pregnancy risk versus levonorgestrel for oral emergency contraception.

June 17, 2010
Paris, France

FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception.

May 21, 2010
Paris, France

HRA Pharma's Partner Preglem Announces Positive Phase III Results for Ulipristal Acetate in the Treatment of Uterine Fibroids.

April 27, 2010
Paris, France

HRA Pharma Announces FDA Advisory Committee Review of Ulipristal Acetate.

April 12, 2010
Paris, France & Geneva, Switzerland

Preglem licenses additional rights for ulipristal acetate from HRA Pharma.

February 11, 2010
Paris, France

HRA Pharma's new emergency contraceptive ellaOne® accepted by the Scottish Medicines Consortium.

February 01, 2010
Paris, France & Morristown, N.J.,
United States

Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.

January 29, 2010
Paris, France

Breaking News in Emergency Contraception: HRA Pharma Unveils Clinical Data on ellaOne®.

December 18, 2009
Paris, France & Madrid, Spain

HRA Pharma Expands to Spain and Launches ellaOne®.

November 9, 2009
Paris, France

HRA Pharma's NorLevo® on its way to becoming the first emergency contraceptive pill available in Japan.

November 9, 2009
Paris, France &
Taipei, Taiwan

HRA Pharma's emergency contraceptive ella® in motion in Asia

October 6, 2009
Paris, France &
Singapore

HRA Pharma Marks First Step for ella® in Asia.

October 1, 2009
Paris, France

HRA Pharma Launches ellaOne® in Europe.

September 23, 2009
Paris, France

HRA Pharma Announces European Marketing and Distribution Agreement with Acrux.

September 18, 2009
Paris, France

HRA Pharma Named Finalist for the 2009 Scrip Awards and the 2009 Clinical Research Excellence Awards.

September 17, 2009
Paris, France &
Roma, Italy

HRA Pharma Reinforces Operational Presence in Europe with Italian Subsidiary.

June 10, 2009
Paris, France

NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada.

July 1, 2009
Paris, France &
London, UK

HRA Pharma Marks Next Step in European Expansion with UK Subsidiary.

May 26, 2009
Paris, France

HRA Pharma Granted European Marketing Authorization for ellaOne®.

May 11, 2009
Paris, France & Geneva, Switzerland

HRA PHARMA AND PREGLEM ANNOUNCE SUCCESSFUL COMPLETION OF PHASE IIB FOR ULIPRISTAL ACETATE FOR THE TREATMENT OF UTERINE FIBROIDS.

April 28, 2009
Paris, France

HRA Pharma Appoints Erin Gainer as CEO to Lead Company Through Next Phases of International Growth.

April 7, 2009
Paris, France

HRA Pharma and Nycomed Reinforce Partnership with Marketing and Distribution Agreement for ellaOne®

March 20, 2009
Paris, France

HRA Pharma Receives CHMP Positive Opinion for ellaOne®

February 17, 2009
Paris, France and Budapest, Hungary

HRA Pharma and Gedeon Richter Enter into Marketing and Distribution Agreement

December 2, 2008
Paris, France and Bochum, Germany

HRA Pharma Strengthens European Operations with German Affiliate.

December 4, 2007
Paris, France

HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders.

November 27, 2007
Bamako, Mali

Being aware that humanitarian programs should not be restricted to the company's area of business, and because cultural development is a necessity for development, HRA has sponsored an award at the "Rencontres africaines de la photographie" aimed to reward the work of a young African photographer who displays unique talent and a potential for excellence.

November 27, 2007
Bamako, Mali

HRA Pharma is sponsoring the "Afrique en créations" prize aimed to reward the work of a young, talented African photographer.

March 26, 2007
Paris, France

HRA Pharma commences UK-based Phase III trial of Ella®, a second-generation emergency contraceptive

February 28, 2007
Paris, France

HRA Pharma invest an additional € 2.5 M in cell therapy through its subsidiary Celogos

February 15, 2007
Paris, France

Stem Cell Sciences and Celogos sign a licensing deal on autogenous myoblast transplantation

December 7, 2006
Paris, France

HRA Pharma commences US Phase III trial of new emergency contraceptive